GlassScriptPhysician profile
James G Burson
NPI 1730161381
$2,197.35
in general payments reported to CMS, 2019-2025
21 companies · $298 in 2025
The $298 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $175 · 2021: $276 · 2022: $378 · 2023: $345 · 2024: $396 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $487.97 | 2019-2025 | |
| Optinose US, INC. | $378.14 | 2019-2025 | |
| Aerin Medical INC. | $265.98 | 2019-2025 | |
| Glaxosmithkline, LLC. | $182.82 | 2021-2025 | Nucala |
| Alk-Abello, INC | $167.03 | 2019-2022 | |
| Stryker Corporation | $149.81 | 2019-2022 | |
| Intersect Ent, INC. | $100.86 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $62.01 | 2019-2025 | Dupixent |
| Acclarent, INC | $60.29 | 2019-2023 | Trudi Nav Cable |
| Ambu INC. | $48.02 | 2025 | |
| Phadia US INC. | $40.93 | 2019-2020 | |
| Spirair, INC. | $40.10 | 2024 | Septalign |
| Integra Lifesciences Corporation | $36.64 | 2022 | |
| Inspire Medical Systems, INC. | $31.47 | 2024 | Inspire |
| Arbor Pharmaceuticals, INC. | $30.56 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $26.99 | 2019-2020 | |
| Amgen INC. | $22.45 | 2025 | Tezspire |
| Phathom Pharmaceuticals, INC. | $20.33 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $17.10 | 2023 | |
| Covidien LP | $15.66 | 2019 | |
| Medtronic USA, INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Burson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.